Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta.
Yang X; Letterio JJ; Lechleider RJ; Chen L; Hayman R; Gu H; Roberts AB; Deng C; The EMBO Journal, 1999, vol. 18, issue 5, p 1280, ISSN 02614189. ISBN 02614189.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef